Claritev Corporation (CTEV)
$36.58-1.85%Close
BUYRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $624M
- Avg volume
- 138.8K
- Beta
- 0.79
- P/E (TTM)
- -2.15
- Short % float
- 12.68%
- Days to cover
- 9.2
- SI change
- -6.5%
- 1W
- +3.48%
- 1M
- +69.27%
- 3M
- +68.80%
- YTD
- +7.94%
- vs SPY 1W
- +4.67%
- vs SPY 1M
- +65.95%
- vs SPY 3M
- +66.41%
- vs SPY YTD
- -3.82%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- LNSRBUYLENSAR, Inc.RECOVERYQ 7$9.23+6.34%
- LONABUYLeonaBio, Inc.RECOVERYQ -24$7.73+0.52%
- CAPRSELLCapricor Therapeutics, Inc.CRISISQ 4$6.80+8.11%
- OGNBUYOrganon & Co.BULLQ -5$13.75+0.00%
- XERSBUYXeris Biopharma Holdings, Inc.RECOVERYQ -2$8.74+0.46%
- SPRBBUYSpruce Biosciences, Inc.RECOVERYQ -3$58.65+13.71%
- BBOTBUYBridgeBio Oncology Therapeutics Inc.RECOVERYQ 3$9.14+0.66%
- ARTVBUYArtiva Biotherapeutics, Inc.RECOVERYQ 14$11.52+5.40%
- CSTLBUYCastle Biosciences, Inc.RECOVERYQ 12$33.47-2.13%
- BDRXBUYBiodexa Pharmaceuticals PlcCRISISQ -27$1.20-5.51%
- PACSSELLPACS Group, Inc.BEARQ 35$44.25+0.00%
- BCYCBUYBicycle Therapeutics plcRECOVERYQ -2$4.33-0.92%
Industry peers
FMP comparable companies · ranked by market cap
- DNTHBUYDianthus Therapeutics, Inc.$6.5BBULLQ 4$115.54-0.93%
- AXGNBUYAxoGen, Inc.$2.7BBULLQ 16$50.19-2.32%
- IARTSELLIntegra LifeSciences Holdings Corporation$1.4BCRISISQ 10$17.55-0.30%
- GDRXBUYGoodRx Holdings, Inc.$1.3BRECOVERYQ -18$3.65-0.29%
- IRMDSELLIRadimed Corporation$1.1BBEARQ 20$87.55-0.76%
- OPKBUYOPKO Health, Inc.$1.0BRECOVERYQ 9$1.36+0.00%
- SANABUYSana Biotechnology, Inc.$1.0BRECOVERYQ -4$3.63-3.32%
- INMDSELLInMode Ltd.$862MBULLQ 16$14.99+0.27%
- EVHBUYEvolent Health, Inc.$515MRECOVERYQ -6$4.58-0.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 21
- VALUE
- 20
- GROWTH
- 39
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC83.7%
REV YoY-
ROE139.6%
EPS YoY-
ROA-5.9%
GROSS44
OP5
NET-28
[VALUATION]
P/E TTM-2.15
P/E FWD-
SECTOR PE22.66
INDUSTRY PE28.61
P/B-2.11
P/FCF-
EV/EBITDA8.86
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.00
ND/EBITDA-
BETA0.79
